When the Technology Works but The System Doesn’t Date: Tue, Apr 7th, 2026 Time: 8:00 am - 8:45 am Location: Online
Speaker:
David Slotwiner, MD Title: Assistant Professor of Medicine
Weill Cornell Medical College, New York Clinical Position(s): Chief, Division of Cardiology Disclosures: None
> Describe the scope of the remote monitoring compliance gap for patients with cardiac implantable electronic devices (CIEDs), including epidemiological data, risk factors and the clinical consequences of system failure.
> Explain how IEEE 11073 nomenclature and FHIR-based data exchange work together to enable interoperability of CIED data across vendors and electronic health record systems.
> Describe the CardX FHIR Accelerator and the World Forum for CIED Follow-up, and their role in translating data standards into commercially available clinical solutions, including the Remote Transceiver Use Case targeting implementation in 2026.
> Identify at least two strategies clinicians can employ — through medical societies, hospital leadership, and industry engagement — to accelerate adoption of interoperability standards for CIED remote monitoring.
Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
NewYork Presbyterian/Queens designates this Live Activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.